Novo Nordisk reprimanded in the UK
Danish drugmaker Novo Nordisk has been reprimanded by British regulators for failing to disclose fees and expenses paid to healthcare professionals and healthcare organisations in Britain, amounting to about 7.8 million pounds between 2020 and 2022.
BELIEBTE BEITRÄGE
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVEÜBERTRAGUNG